Further gene transcript paneling of genes related to cancer activity in cells also showed no changes with both nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κβ), and B‐cell lymphoma 2 (BCL‐2) expression. This evidence concerns the gene NFKB1 and cancer.